Alessandra Tucci

13.8k total citations
143 papers, 2.6k citations indexed

About

Alessandra Tucci is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Alessandra Tucci has authored 143 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Pathology and Forensic Medicine, 44 papers in Oncology and 41 papers in Genetics. Recurrent topics in Alessandra Tucci's work include Lymphoma Diagnosis and Treatment (85 papers), Chronic Lymphocytic Leukemia Research (35 papers) and Viral-associated cancers and disorders (17 papers). Alessandra Tucci is often cited by papers focused on Lymphoma Diagnosis and Treatment (85 papers), Chronic Lymphocytic Leukemia Research (35 papers) and Viral-associated cancers and disorders (17 papers). Alessandra Tucci collaborates with scholars based in Italy, United States and Switzerland. Alessandra Tucci's co-authors include Giuseppe Rossi, Chiara Bottelli, Erika Borlenghi, Francesco Bertagna, Alessandro Re, Domenico Albano, Samantha Ferrari, Monica Drera, Luigi Rigacci and Rudolf H. Zubler and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Alessandra Tucci

127 papers receiving 2.6k citations

Peers

Countries citing papers authored by Alessandra Tucci

Since Specialization

Citations

This map shows the geographic impact of Alessandra Tucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Tucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Tucci more than expected).

Fields of papers citing papers by Alessandra Tucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Tucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Tucci. The network helps show where Alessandra Tucci may publish in the future.

Co-authorship network of co-authors of Alessandra Tucci

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Tucci. A scholar is included among the top collaborators of Alessandra Tucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Tucci. Alessandra Tucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early identification of functional high-risk multiple myeloma patients after transplant: the predictive power of fat fraction and Response Assessment Category score in diffusion-weighted whole-body magnetic resonance imaging 2025 ·Haematologica ·Angelo Belotti, Barbara Frittoli, (unknown), Rossella Ribolla, Claudia Crippa, (unknown), Samantha Ferrari, (unknown), Chiara Bottelli, Chiara Cattaneo, Carmine Carbone, (unknown), Marco Chiarini, Viviana Giustini, Aldo M. Roccaro, Luigi Grazioli, Alessandra Tucci	0
2	Phase 2 bellwave-003 cohort f: Updated clinical outcomes of nemtabrutinib in participants with relapsed or refractory marginal zone lymphoma 2025 ·Blood ·Alessandra Tucci, Yair Herishanu, (unknown), Sarit Assouline, Lori A. Leslie, (unknown), Pier Luigi Zinzani, Yan Xu, Mohammed Z.H. Farooqui, Jing Yang, Muhıt Özcan	0
3	The role of baseline 2‐[ ¹⁸ F]‐FDG‐PET/CT metrics and radiomics features in predicting primary gastric lymphoma diagnosis 2024 ·Hematological Oncology ·Domenico Albano, (unknown), Francesco Dondi, (unknown), Alessandra Tucci, Francesco Bertagna	8
4	A Phase II Clinical Study Exploring the Safety and Efficacy of the Oral PI3Kδ Inhibitor, Linperlisib, in Relapsed Refractory T Cell Lymphoma 2024 ·Blood ·Swaminathan P. Iyer, Ranjit Nair, Neha Mehta–Shah, Don A. Stevens, Alessandra Tucci, António Pinto, Pier Luigi Zinzani	1
5	2-[18]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome 2024 ·Annals of Hematology ·Domenico Albano, (unknown), (unknown), Francesco Dondi, Chiara Pagani, Alessandra Tucci, Giorgio Treglia, Francesco Bertagna	2
6	Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple Myeloma 2024 ·Advances in Radiation Oncology ·Andrea Emanuele Guerini, (unknown), Paolo Borghetti, Luca Triggiani, (unknown), (unknown), (unknown), Alessandra Tucci, Angelo Belotti, Marco Lorenzo Bonù, (unknown), Stefano Maria Magrini, Luigi Spiazzi, Michela Buglione	0
7	Trial in Progress: A Phase II Trial to Investigate Venetoclax in Combination with Ibrutinib and Rituximab or Conventional Chemoimmunotherapy (Bendamustine and Rituximab) and Ibrutinib in Patients with Treatment-Naive Mantle Cell Lymphoma Not Eligible for High-Dose Therapy - MCL Elderly III 2024 ·Blood ·(unknown), Anke Ohler, (unknown), Christian Schmidt, Michael Unterhalt, Eva Hoster, (unknown), Susanne Singer, (unknown), Marco Ladetto, Alessandra Tucci, Christiane Pott, Georg Heß, Martin Dreyling	0
8	IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO POLA‐R‐CHP TREATMENT REDUCES TUMOR MICROENVIRONMENT DEPENDENCY 2023 ·Hematological Oncology ·Franck Morschhauser, Katerina Hatzi, Georg Lenz, Alex F. Herrera, Christopher R. Flowers, Marek Trněný, John M. Burke, Jian Hou, Philipp B. Staber, Eliza A. Hawkes, Koji Izutsu, Steven Le Gouill, David Belada, Alessandra Tucci, (unknown), (unknown), Jamie Hirata, Chengkuo Lee, Yanwen Jiang, Fabrice Jardin	1
9	18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor? 2023 ·Cancers ·Domenico Albano, Giorgio Treglia, Francesco Dondi, (unknown), Alessio Rizzo, Salvatore Annunziata, Luca Guerra, Silvia Morbelli, Alessandra Tucci, Francesco Bertagna	20
10	Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT 2023 ·Bone Marrow Transplantation ·(unknown), Myriam Labopin, Thomas Pabst, Xi Zhang, Erlie Jiang, Alessandra Tucci, Jan J. Cornelissen, Ellen Meijer, (unknown), Emmanuelle Polge, Depei Wu, Mohamad Mohty, Norbert Claude Gorin	4
11	Predictive role of sustained imaging MRD negativity assessed by diffusion‐weighted whole‐body MRI in multiple myeloma 2023 ·American Journal of Hematology ·Angelo Belotti, Rossella Ribolla, Claudia Crippa, Marco Chiarini, Viviana Giustini, Samantha Ferrari, Annalisa Peli, Chiara Cattaneo, Aldo M. Roccaro, Barbara Frittoli, Luigi Grazioli, Giuseppe Rossi, Alessandra Tucci	5
12	RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 2022 ·Cancers ·Andrea Emanuele Guerini, Alessandra Tucci, Filippo Alongi, (unknown), Angelo Belotti, Paolo Borghetti, Luca Triggiani, (unknown), Sara Pedretti, Marco Lorenzo Bonù, Davide Tomasini, (unknown), (unknown), (unknown), (unknown), (unknown), Cesare Tomasi, Stefano Maria Magrini, Luigi Spiazzi, Michela Buglione	4
13	Longitudinal Body Composition Changes Detected by [18F]FDG PET/CT during and after Chemotherapy and Their Prognostic Role in Elderly Hodgkin Lymphoma 2022 ·Cancers ·Domenico Albano, Francesco Dondi, Giorgio Treglia, Alessandra Tucci, Marco Ravanelli, Davide Farina, Francesco Bertagna	9
14	Prognostic Role of "Radiological" Sarcopenia in Lymphoma: A Systematic Review 2021 ·Clinical Lymphoma Myeloma & Leukemia ·Domenico Albano, Francesco Dondi, Marco Ravanelli, Alessandra Tucci, Davide Farina, Raffaele Giubbini, Giorgio Treglia, Francesco Bertagna	10
15	Prognostic impact of TP53 mutation in newly diagnosed diffuse large B‐cell lymphoma patients treated in the FIL‐DLCL04 trial 2021 ·British Journal of Haematology ·Annalisa Chiappella, Fary Diop, Claudio Agostinelli, Mattia Novo, Luca Nassi, Andrea Evangelista, Giovannino Ciccone, Alice Di Rocco, Maurizio Martelli, Federica Melle, Riccardo Moia, Giovanna Motta, Simona Righi, (unknown), Alessandra Tucci, Monica Balzarotti, Marco Ladetto, Stefano Pileri, Gianluca Gaïdano, Umberto Vitolo, (unknown)	21
16	Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88 2020 ·Blood ·Antonio Sacco, Cinzia Federico, Arianna Giacomini, (unknown), Federica Maccarinelli, Katia Todoerti, (unknown), Antonella Anastasia, Marina Motta, Domenico Russo, Giuseppe Rossi, (unknown), Riccardo Castelli, Antonino Neri, Roberto Ronca, Chiara Cattaneo, Alessandra Tucci, Marco Mor, Marco Presta, Aldo M. Roccaro	6
17	slan+ Monocytes and Macrophages Mediate CD20-Dependent B-cell Lymphoma Elimination via ADCC and ADCP 2018 ·Cancer Research ·William Vermi, Alessandra Micheletti, (unknown), Cristina Tecchio, Federica Calzetti, Sara Costa, Mattia Bugatti, Stefano Calza, Claudio Agostinelli, Stefano Pileri, Piera Balzarini, Alessandra Tucci, Giuseppe Rossi, (unknown), Giuseppe Todeschini, Alberto Zamò, Fabio Facchetti, Luisa Lorenzi, Silvia Lonardi, Marco A. Cassatella	29
18	Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study 2008 ·Annals of Oncology ·Alessandro Re, Silvia Ferrari, Paolo Frata, Claudio Pizzocaro, Claudia Crippa, Alessandra Tucci, Fabio Facchetti, Luigi Grazioli, Stefano Maria Magrini, Giuseppe Rossi	2
19	Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma 2008 ·Annals of Oncology ·Luca Arcaini, Francesca Montanari, Emilio Paolo Alessandrino, Alessandra Tucci, Ercole Brusamolino, Livio Gargantini, Roberto Cairoli, Paolo Bernasconi, Francesco Passamonti, Maurizio Bonfichi, Valerio Zoli, Chiara Bottelli, Silvia Calatroni, (unknown), Michele Merli, Cristiana Pascutto, Ignazio Majolino, Giuseppe Rossi, Enrica Morra, Mario Lazzarino	25
20	CHOP Chemotherapy Plus Campath-1H (CHOP-C) as First Line Treatment in Patients with Peripheral T-Cell Lymphoma (PTCL). 2005 ·Blood ·Andrea Gallamini, Francesco Zaja, Livio Gargantini, Annunziata Manna, (unknown), Alessandro Levis, Luigi Rigacci, Patrizio Mazza, Emilio Iannitto, Antonio Pinto, Alessandra Tucci, Caterina Patti, Valerio Zoli, Alessandro Federico	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact